Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Early Phase Study of KESONOTIDE™in Participants With Solid TumoursAdnexal Diseases, Digestive System Diseases, Digestive System Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, Thoracic Neoplasms, Urogenital Diseases, Urogenital Neoplasms, astrocytoma (excluding glioblastoma), breast cancer, breast disorder, breast neoplasm, endocrine system disorder, epithelial neoplasm, female reproductive system disorder, female reproductive system neoplasm, glioblastoma, glioma, gonadal disorder, lung cancer, lung disorder, lung neoplasm, male reproductive organ cancer, male reproductive system disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, neuroepithelial neoplasm, ovarian cancer, ovarian disorder, pancreas disorder, pancreatic neoplasm, primitive neuroectodermal tumor, prostate cancer, prostate disorder, respiratory system disorder, respiratory tract neoplasm, skin disorder, skin neoplasmRecruitingPhase 1 / Phase 22026-03-17NCT06926075

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Filamon LTD2

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
South Western Sydney Local Health DistrictLiverpoolAustralia2
Southside Cancer CentreMirandaAustralia1
St George Private HospitalKogarahAustralia5